Home › Degenerative Nerve Diseases › Massachusetts › Boston
Degenerative Nerve Diseases clinical trials in Boston, MA
5 studies for Degenerative Nerve Diseases are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
RecruitingPhase 1/2
- Massachusetts General Hospital /ID# 270960, Boston
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Massachusetts General Hospital - Charlestown, Charlestown · 1 mi away
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecruitingPhase 1
- Massachusetts General Hospital (MGH), Charlestown · 1 mi away
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
- Boston University, Boston
- Massachusetts General Hospital, Boston
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
RecruitingObservational study
- Boston Children's Hospital, Boston
About Degenerative Nerve Diseases
Neurodegenerative (degenerative nerve) diseases are disorders that destroy motor neurons. Parkinson's is an examples. See a list of all the diseases.
More about Degenerative Nerve Diseases on MedlinePlus
Degenerative Nerve Diseases trials in other cities
- Philadelphia, PA6 studies
- Tampa, FL5 studies
- Orlando, FL5 studies
- San Diego, CA4 studies
- Scottsdale, AZ4 studies
- Atlanta, GA4 studies
- San Francisco, CA3 studies
- Farmington Hills, MI3 studies
- Miami, FL3 studies
- Gainesville, FL3 studies
- West Palm Beach, FL3 studies
- Denver, CO3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.